Member Info for rhodi

Do not want to sound flippant but it is probably the least of our worries with this share. More concerned with a big drop then a big rise and who profited. Tempting to report to regulatory body to investigate but they are probably snowed under with similar IMHO. If I had the spare time I would. To busy working longer hours than I should due to an under performing share, in an underperforming Company with underperforming personnel IMHO.The SP would back that up. The recruitment and lack of advancement would back that up. The fact that we continually change Nomads would back that up. The fact that we could not hold on to KAB would back that up. The fact that bonuses and pay are not performance related would back that up. Mediocrity in one word sums this share up and probably over generous.

Sorry as sent from phone.

Thelix you are quite correct.powers of b will have made a nice little earner.take it down 10% thenraise it 20%not a bad liþle earner. The pnlly people getting rich from this is broker:nomads and jak and bod imho.No real interest in commercialisation I am beginning to think.all imho.roll on 2020 or 2030.

Means more dilution. But why they have an option I have no idea as they are no longer our nomad. IMHO we are being shafted by Jak and the BOD once again. Like I say we will be lucky if we get £3 by the year 2020. As I said last time surely with the money they all get paid they could at least release a B side to the record. Same old shit but at least they are consistent and it is only the depth that varies with this share imo. I would like to say that it cannot get worse but I think it probably can.

I ads on the nasdaq exchange is the equivalent of 8 aim. Plus then just do a currency conversion. NAsdaq closed yesterday at $16.66 and we today stand at £1.52 ish (x8= 12.16 = $16.01........in effect todays rise is us just catching up with the Nasdaq). Hope that helps. Still good to see blue.

have made there 20% and will no doubt be taking profits in the next few days.

Market manipulation at it's best. Funny coincidence. lol

20% increase. Congratulations.

when we actually get our investment back, So they have a long long wait at the moment. Plus too many congrates may tempt them to increase their next years awards. Not they need any proper reason as it has never stopped them in the past.

The data could have been better but that is obvious.It could have been worse and that would have surprised us all. at 134p is equivalent to $14 ADS on Nasdaq currently sitting at $14.92 and 29% up. Happy to see blue.

Have sold some more shares whilst SP at a high and will re buy more when the excitement and SP dies awaiting next results. May as well try and increase my shares this way so that I can lower my average. Nothing to lose really. Not like I can get caught short as long as I am in during 2020.

Pleased for you and hopefully you will have bought in at the right time so that you can double your money in two three years time which is a good investment. Most of us have seen our investment at least halved and in many cases a lot worse. Good luck to you and welcome to the BB. My worry is that in an uncertain world we have not allowed for any market crashes due to political uncertainties to name North Korea for one. So a quick commercialisation would have been most appropriate but that is clearly not happening till 2020 if what they said at the AGM was anything to go by and that I would expect would be in line with Vernalis patent maybe lapsing, unfortunate for Vernalis but then they should be more aware than anyone how long a drug takes to get to commercialisation.

No Pharma has been interested in this from the start IMHO and certainly not at what the BOD would consider as a resonable offer. Why would anyone make an offer for a drug that is an ADD ON. The only advantage to that would to be to re patent any products that are nearing the end of their patents and those give a market advantage but not what any off us expected on what they have been previously saying. I think we expected more in line with what we were originally told "Significant shareholder value " which it clearly currently is not unless you can point to anything that I may have overlooked. IMHO Nothing changes till commercialisation and only the traders will benefit as we have seen in the last three days. Wish I had done the same.

Why could it be interesting? Or do you think they may react differently as they are not numbed by all the years we have read samy samy. Expect it to maybe increase in line with this. Lets be honest the shares are all held in the USA by I suspect mainly ii's and they need another 10 % on top of today before they even break even and then they will hold. Anyone wanting to buy shares will wait until the next dilution from another Global offering IMHO.

SP = £1.50 before joining nasdaq. After joining nasdaq and results from this trial and further trial and any CF news and having spent 20-30million on trials etc. I envisage £1.50- £1.60 and probably being over optimistic come May and June next year. Sorry that does not get me excited. listen if an investor buys shares now they may just double money on commercialisation. IN TWO YEARS TIME mInimum. investors may as well just buy in prior to 2020 IMHO.

Have read them and all one big yawn. Have read samy samy ever year ,so no bloody different IMHO. But glad you and bladeboy are so excited maybe that excitement will continue to next AGM when the sp will be no more forward than it was prior to the trials £1.50.

At least a better COPD product maybe. But we all expected these results and we I think all get it. BUt are there some more drugs that we can be tested as an Add on with . I am sure there must be just to keep this ticking along nicely until 2020. Then are patents will have 10-15 years to run up until 2035. I will be 75 by then and whilst not having any financial benefit from supporting the company, I may at least get to use the drug I helped to sort of sponsor. So it will all be worth while after all. Thanks JAK and Co ...keep up the great trials that are fast tracking this companys elevation in the conducting of successive successful trials( must be an award for that somewhere) and for the Mysteriously low Sp that continues to bare no correlation (must be another award for that also). ALL IMHO

the last three days of trades it appears IMHO that the news is not as water tight as it once was in this company. We need that plumber. How many more trials then bewise 5 or 6. Then maybe we will be edging closer towards £1.50-£1.75p taking the usual dips between trials into account say at a cost of 20-30million. No wonder investors haven't the energy, inclination or stamina to attend an AGM. Once you have been to one you have been to all as it is just a repeat performance each year, great results from trials, no advancement in SP, More bonus awards for the hard work of organising cracking trials and lowering sp. All imho.

You can smile again? Back in the blue and we are still only 25p down on the SP that we where at prior to this trial starting. Puts this company's progress into perspective and reiterates the current dilemma that we shareholders with this share. Same ol same ol.

and yet still several steps back. Roll on 2020 if I am still here to see it.